About Us

Our mission is to
accelerate science

10x Genomics is building tools for scientific discovery that reveal and address the true complexities of biology and disease. Through a combination of novel microfluidics, chemistry and bioinformatics, our award-winning Chromium System is enabling researchers around the world to more fully understand the fundamentals of biology at unprecedented resolution and scale.

Board Members

Serge Saxonov Chief Executive Officer, Co-founder

Serge Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. He defined vision and strategy, contributed to core inventions, and led the company through multiple phases of rapid growth. In 2016, he was honored as one of Goldman Sachs 100 Most Intriguing Entrepreneurs of the Year. Prior to 10x Genomics, Serge was VP of Applications at QuantaLife, where he was responsible for building content, driving new applications, and identifying key diagnostics opportunities for the core ddPCR technology. Before QuantaLife, Serge was Founding Architect and Director of R&D at 23andMe. There he defined the initial conception of the product, built many elements of the technology, and drove strategy and execution of R&D functions as the company scaled. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics and biology from Harvard College.

Ben Hindson Chief Scientific Officer, President, Co-founder
Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. Prior to 10x Genomics, Hindson was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad in 2011. From 2002 to 2008, he served in various positions of increasing responsibility at Lawrence Livermore National Laboratory, in the Chemical and Biological Weapons Non-proliferation Program. He has published extensively in his field and holds many patents for assays and instrumentation. Hindson earned his BSc in Chemistry in 1998 and his PhD in Chemistry in 2001 from Deakin University, Australia.
Paul Conley Board of Directors
Paul Conley has served on the Board of Directors since November of 2013. Dr. Conley leads new investments for Paladin Capital Group while serving as an active Director on many of Paladin’s portfolio company Boards. Paul joined the Paladin team after more than 15 years of previous R&D and entrepreneurial experience. As founding CEO of BrightScale, he led the commercialization of a patented multi-core microprocessor technology in the HDTV market. As founding CEO of Appfluent Technology, he led the commercialization of patented in-memory distributed database technologies in the enterprise IT market. Prior to taking the entrepreneurial route, he spent nearly a decade in multidisciplinary R&D roles in the areas of high-performance computing, applied physics and biomedical engineering, including postdoctoral positions at the Los Alamos National Laboratory. Paul earned a PhD in Computational Physics and an MS in Bioengineering from UCSD, as well as an MS and BS in Mechanical and Aerospace Engineering from the University of Virginia.
Bryan Roberts Board of Directors
Bryan Roberts, Ph.D. has served on the Board of Directors since November of 2013. Bryan joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and focuses on a broad range of healthcare investments. Bryan is currently Chairman of the Board of Directors of Achaogen (NASDAQ: AKAO), Castlight Health (NYSE: CSLT), Ironwood Pharmaceuticals (NASDAQ: IRWD), and Kyruus and also serves on the Board of several other companies, including 10X Genomics, Doctor on Demand, Grand Rounds, Intarcia, and Zeltiq (NASDAQ: ZLTQ). Past investments include Ariosa Diagnostics (acquired by Roche), athenahealth (NASDAQ: ATHN), CodeRyte (acquired by 3M), Ikaria (acquired by Madison Dearborn), Illumina (NASDAQ: ILMN), and Sirna Therapeutics (acquired by Merck). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and is the only healthcare investor to rank on Forbes’ Midas List six times, 2008 – 2014. Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He previously held positions in corporate finance at Kidder, Peabody & Co and received his B.A. from Dartmouth College.
Mathai Mammen Board of Directors

Dr. Mammen’s mission is to work with the best research and development professionals in the world to make meaningful medicines that impact the lives of patients, their families and communities.

Prior to joining Janssen in June 2017, Dr. Mammen was Senior Vice President at Merck Research Laboratories, responsible for research in the areas of Cardiovascular, Metabolic and Renal Diseases, Oncology/Immuno-Oncology and Immunology. Jointly with his team, he initiated numerous new programs and progressed eight into early clinical development. He also nucleated a new discovery site in the San Francisco Bay Area.

Prior to Merck, Dr. Mammen led R&D at Theravance, a company he co-founded in 1997 based on his work at Harvard University. Under his leadership, the Theravance team of 200 scientists nominated 31 development candidates in 17 years, created three approved products (Breo®, Anoro®, Vibativ®), two additional assets that have successfully completed Phase 3 studies and a pipeline containing 11 further development-stage compounds in 2016. In 2014, he and the Theravance Leadership Team separated Theravance into two publicly traded companies: Innoviva (INVA) and Theravance Biopharma (TBPH).

Dr. Mammen has more than 150 peer-reviewed publications and patents and serves on various boards and advisory committees. He received his M.D. from Harvard Medical School/Massachusetts Institute of Technology (HST program) and his Ph.D. in Chemistry from Harvard University’s Department of Chemistry, working with George Whitesides. He received his BSc in Chemistry and Biochemistry from Dalhousie University in Halifax, Nova Scotia.

John Stuelpnagel Chairman
John Stuelpnagel has been Chairman of 10x Genomics since August of 2013. In addition, John co-founded and was Executive Chairman of Ariosa from 2010 to 2015 when the company was acquired by Roche. He was also the Chairman of Sequenta from 2010 to 2015 when that company was merged with Adaptive Biotechnologies where he continues as a Member of the Board. Previously, John co-founded Illumina, Inc. and was instrumental in making Illumina one of the most successful life science companies. During his 12 years at Illumina, John served as the company’s first CEO and most recently served as COO. Prior to Illumina, John was a venture capitalist at CW Group. John received his B.S. in Biochemistry and his Doctorate in Veterinary Medicine from the University of California, Davis and his M.B.A. from the University of California, Los Angeles.

Pleasanton, CA

10x Genomics
7068 Koll Center Parkway,
Suite 401
Pleasanton, CA 94566
+1 925 401 7300
+1 800 709 1208

San Francisco, CA

10x Genomics
160 Spear St.,
Suite 1130
San Francisco, CA 94105
+1 925 401 7300
+1 800 709 1208

Leiden, The Netherlands

10x Genomics B.V.
Crown Business Center Key Point II,
Schipholweg 103,
2316 XC Leiden,
The Netherlands
+31 (20) 888 6622

Stockholm, Sweden

Spatial Transcriptomics,
Part of 10x Genomics, Inc
Södra Fiskartorpsvägen 15C,
114 33 Stockholm,


10x Genomics Pte Ltd
Science Park 2,
20 Science Park Road,
#02-32A/33 Teletech Park,
Singapore 117674

Shanghai, China

10x Genomics (Shanghai) Co., Ltd
2421, Cloud 9 International Plaza,
No 1018 Changning Road,
Shanghai, 200042 China

Join our expanding network of global distributors!

Australia and New Zealand
Decode Science Pty Ltd
Monash Enterprise Centre
5a Hartnett Close
Mulgrave, Victoria 3170
DAON BioSciences Inc.
1808, 79 Nonhyeon-ro,
Seoul, 06775 Korea
Tel: +82 2 575 6227
Fax: +82 2 575 6228
Southeast China and Hong Kong
Biostar Technology Limited
Room 4D, Building 3
No. 401 Cao Bao Rd
Xuhui District
Shanghai 200233, China
Tel: +86 21 34250079
Fax: +86 21 64398697

North China
Beijing Emei Tongde Technology Development Co.,Ltd. (EMTD)
Room 401, Building 10, Beijing Link 
No. 6 Court JingShun East Street 
Chaoyang District
Beijing 100015, China

Tel: +10 8440 9662-602
Fax: +10 8400 9672
Pharmigene, Inc.
4F., No. 17, Ln. 171, Sec. 2, Jiuzong Rd., 
Neihu District
Taipei  City 11494, Taiwan
Tel: +886 2 2798 5885 
Fax: +886 2 2798 6300 
Singapore, Malaysia, Thailand, Indonesia, Philippines, Brunei, Vietnam
Research Instruments Pte Ltd
47 Ayer Rajah Crescent #03-12
Republic of Singapore 139947
Tel: +65 6571 0888
Fax: +65 6571 0868
Kawakoshi Bldg. 3-9-2
Midori, Sumida-ku Tokyo 130-0021
Tel: +81 (0)3 5625 9711
Fax: +81 (0)3 3634 6333
Middle East/Africa
Middle East: Bahrain, Iraq, Jordan, Kuwait, Lebanon, Oman, Palestinian Authorities, Qatar, Saudi Arabia, United Arab Emirates, Yemen
Africa: Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Congo, Democratic Republic of Congo, Djibouti, Egypt, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Ivory Coast, Kenya, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Mauritius, Morocco, Mozambique, Namibia, Niger, Nigeria, Rwanda, Senegal, Sierra Leone, South Africa, Swaziland, Tanzania, Togo, Tunisia, Uganda, Zambia, Zimbabwe
Alliance Global FZ – LLC
Office 1610, Concord Tower
Dubai Media City
P.O. Box 500392
Dubai – UAE Tel: +971 4 375 2-44
Fax: +971 4 429 1376
Premas Lifesciences Pvt. Ltd.
E-49/5, 2nd Floor
Okhla Industrial Area, Phase II
New Delhi – 110020
Russia, Kazakhstan, Uzbekistan, Armenia, Belarus, and Kyrgyzstan
Skygen LLC
Lyusinovskaya Street, 36/1
Moscow 115093
Tel: +7 (495) 215-02-22
Fax: +7 (495) 215-02-22
OMNIGEN Medical Products Corporation
Tozkoparan Mah. Haldun Taner Sokak No:27 D:7
Alparslan İş Merkezi Merter-Güngören
Tel: 0212 481 3 444 pbx
Fax: 0212 481 5 444
Omega d.o.o.
Dolinškova 8
1000 Ljubljana
Tel: +386 1 4273213
Fax: +386 1 4273191
Czech Republic, Hungary, and Slovakia
GeneTiCA s.r.o.
Sluzeb 4
108 00 Praha 10
Czech Republic
Tel: +420 272 701 055
Fax: +420 272 653 241
Greece, Romania, Bulgaria
Antisel S.A.
Spectra building, 12th km
Thessalonikis- N.Moudanion str.,
57001 Thermi
Tel: +30 231 0322525
Fax: +30 231 0321912
Perlan Technologies Polska Sp. z o.o
Pulawska 303
02-785 Warsaw
Tel: +48 22 549 14 00
Fax: +48 22 549 14 01
Bonsai Advanced Technologies, SL
Avda. Valdelaparra, 27
28108 – Alcobendas
Tel: +34914902334
Fax: +34914841313
ILC-Instrumentos de Laboratório e Científicos, lda
Rua Dr. Álvaro de Castro, nº 77
1600-058 Lisboa
Tel: + 351 217826030
Fax: + 351 217826039
CARLO ERBA Reagents S.r.l.
Via Merendi 22 – 20010 Cornaredo (Mi)
Tel: +39 02 93991003
Analitek, SA de CV
Lomas de los pinos 5505-A Col La Estanzuela Vieja
Monterrey Nuevo León
Tel: (81) 8104 0267

Mexico City Office
Amores 707-203 Col del Valle CDMX
Tel. (55) 5543 1442
Tel. 01 800 733 2625
Argentina, Uruguay and Chile
BioSystems S.A.
Av. Dorrego 673
CABA – República Argentina
Tel: +54 1148547775

We invite interested distributors to email

Order your 10x system, today.